New cholera vaccine trial aims to protect south africans of all ages
NCT ID NCT07304284
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests a new oral cholera vaccine (Biovac OCV-S) in about 2,824 healthy people aged 1 to 45, including adults living with HIV. The goal is to see if the new vaccine triggers a strong immune response and is as safe as an already-approved vaccine (Euvichol-Plus). Participants will receive two doses, and researchers will check blood antibody levels and track any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLERA VACCINATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Perinatal HIV Research Unit (PHRU)
RECRUITINGJohannesburg, Gauteng, 1862, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SAMRC Chatworth CRS
RECRUITINGDurban, KwaZulu-Natal, 4092, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SAMRC Isipingo CRS
NOT_YET_RECRUITINGDurban, KwaZulu-Natal, 4110, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Synergy Biomed Research Institute
NOT_YET_RECRUITINGDurban, Eastern Cape, 5201, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit
NOT_YET_RECRUITINGJohannesburg, Gauteng, 1862, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.